Publications

Featured Publications

INOVIO is focused on rapidly bringing to market precisely designed DNA medicines to potentially treat and protect people from diseases associated with HPV, cancer, and infectious diseases. In the last several years INOVIO has had its data published in several prominent peer-reviewed medical journals including:

Other Development Candidates

Title Disease Target Product
DNA-encoded bispecific T cell engagers and antibodies present long-term antitumor activity
JCI Insight — April 2019
HER2